Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_36671
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 36671
Character Range: 1880262–1882015

36671                         Percutaneous tibial nerve stimulation, initial treatment protocol, for the treatment of overactive bladder, by a specialist urologist, gynaecologist or urogynaecologist, if:                                                                                                                                                                                                                                                                                                   208.10
                              (a) the patient has been diagnosed with idiopathic overactive bladder; and
                              (b) the patient has been refractory to, is contraindicated or otherwise not suitable for, conservative treatments (including anti‑cholinergic agents); and
                              (c) the patient is contraindicated or otherwise not a suitable candidate for botulinum toxin type A therapy; and
                              (d) the patient is contraindicated or otherwise not a suitable candidate for sacral nerve stimulation; and
                              (e) the patient is willing and able to comply with the treatment protocol; and
                              (f) the initial treatment protocol comprises 12 sessions, delivered over a 3 month period; and
                              (g) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes
                              Applicable only once, unless the patient achieves at least a 50% reduction in overactive bladder symptoms from baseline at any time during the 3 month treatment period
                              Not applicable to a service associated with a service to which item 36672 or 36673 applies